Skip to main content

Advertisement

Table 6 Glycemic control and glucose-lowering therapy for pregnant women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) in Kronoberg

From: Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden

N T1DM T2DM P
37 11  
Glycemic control
HbA1c 1st trimester (mmol/mol) 56 ± 15 49 ± 14 0.14
(Min/max) 32–113 35–73  
HbA1c 2nd trimester (mmol/mol) 49 ± 12 42 ± 6 0.047
(Min-max) 31–82 36–52  
HbA1c 3rd trimester (mmol/mol) 48 ± 11.1 42 ± 7 0.09
(Min-max) 29–80 34–54  
Therapy
Type of therapy (insulina vs diet) 36 (97%) 8 (73%) 0.03
Daily dose of basal (weeks 26–28) (units) 28 ± 20.2 25 ± 40.2 0.73
Daily dose of basal at (delivery) (units) 32 ± 21.8 31 ± 39.2 0.92
Daily dose of bolus (weeks 26–28) (units) 48 ± 29.4 26 ± 27.4 0.04
Daily dose of bolus at (delivery) (units) 57 ± 31.3 40 ± 34 0.14
  1. Data are expressed as means ± standard deviation or n (%)
  2. aFor insulin substances please see the text